Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 Applied in a Split-face (Left/Right) Topical Design in Adults With Moderate to Severe Acne
Phase of Trial: Phase II
Latest Information Update: 09 May 2017
At a glance
- Drugs Ingenol disoxate (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 04 May 2017 Status changed from active, no longer recruiting to completed.
- 19 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Apr 2017.
- 19 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Apr 2017.